A treatment the mainstream has been trying to kill for decades just may hold the secret to adding years to your life. And the proof is now so rock solid, even conventional doctors are going to have to take a second look.
I’m talking about intravenous chelation therapy, which can attract, capture, and sweep toxins out of your body, especially heavy metals that can attack everything from your heart to your brain.
The American College for Advancement in Medicine (ACAM, a non-profit organisation of which I’m a member) has been teaching physicians how to perform chelation therapy for over 30 years.1 Still, many mainstream doctors – and even groups like the American Heart Association – have done everything they can to blacklist chelation.
But a major study has definitively proven that chelation can help with everything from heart disease to diabetes. And this treatment that has spent too long in the shadows may now be ready for prime-time.
One small step for chelation therapy… one giant leap for cardiovascular disease
ACAM first partnered with the National Institutes of Health (NIH) in 2003 to produce even MORE proof of how chelation can be used to successfully treat cardiovascular disease.
Their joint, large-scale study called the Trial to Assess Chelation Therapy (TACT) involved a course of 40 ethylene diamine tetraacetic acid (EDTA) chelation infusions – just like the ones we’ve all been giving for years. Over 1,700 patients across 134 sites in both the US and Canada received a total of 55,222 infusions. They were randomized to receive either (a) intravenous chelation and oral vitamins, or (b) placebo chelation and placebo vitamins.
In the end, the EDTA-based chelation therapy reduced overall cardiovascular events (heart attacks, strokes, etc.) in patients who had some history of prior heart attacks and were being treated medically. Not only that, but IV EDTA chelation therapy and high-dose oral vitamin therapy significantly reduced cardiovascular events when combined with standard medical therapy as compared to standard medical therapy combined only with a placebo.2
And that’s not the only good news that came out of TACT. Chelation therapy actually outperformed statins in terms of preventing cardiovascular events, especially among diabetics.3 Adding oral high-dose vitamins seems to have made the EDTA effects for diabetics even greater.
And the best news of all? EDTA chelation has a remarkable safety history, while statin therapy causes all sorts of side effects, some quite dangerous.
Throw away the one bad apple that’s spoiling the bunch…in your body
To be honest, we don’t yet know exactly why chelation might work for cardiovascular disease – which is why studies like TACT are so important. Right now the resounding theory is that it removes the metals in your body that can cause the abnormal proteins and oxidative stress that can lead to circulatory damage and diabetes.
Lead and cadmium in particular seem to enhance oxidative stress and cell damage, and chelators like EDTA act as a powerful antioxidant when introduced to a toxic environment like that.
These processes of oxidation are sometimes called ‘browning reactions’, because they’re the same thing that toasts your bread, caramelises your onions, and turns your apples brown. And, like food, once the walls of our vessels are ‘browned’, they can’t ever go back.
EDTA has been known to block the browning reaction – at least, in chemical studies on food. And it may have the same reaction in the human body – but to find out for sure, human clinical trials are needed.
It’s going to take a littlemore convincing
You would THINK that the prospect of a safe and effective therapy would excite mainstream cardiologists, but the TACT results don’t seem to have impressed the American Heart Association very much. Their latest recommendations state that “the usefulness of chelation therapy in cardiac disease is highly questionable”.4
Well, any good researcher would tell you that one study by itself shouldn’t be considered proof positive – no matter how good the design – so the principal investigators from TACT have submitted an application and are seeking funding for a follow-up study to see if they can get the same positive results a second time. The design of the so-called ‘TACT2’ will be the same as TACT1, involving 1,200 diabetic patients aged 50 or older who have had heart attacks prior to the study.5
Hopefully, the results will be positive enough to finally convince those bubble-bursting naysayers that there IS a safe and effective alternative to statins and surgery, and that there’s PROOF of it.
In the meantime, physicians like myself are continuing to see the positive effects of this remarkable therapy first-hand in patients like you, in hundreds of surgeries globally.
I’m keeping my eyes on this story, and will be sure to update you on any new developments as they happen.
Dr. Glenn S. Rothfeld
Nutrition & Healing
Vol. 10, Issue 2 • February 2016
Full references and citations for this article are available in the downloadable PDF version of the monthly Nutrition and Healing issue in which this article appears.